GLP-1 is a natural incretin hormone produced by the intestines in response to food intake
[10] Constipation, headache, shortness of breath, increased plasma bilirubin, decreased levels of gamma glutamyl transferase, lactate dehydrogenase, and aspartate aminotransferase are only a few of the possible adverse responses and side effects of NAD+ injection
Modern peptide synthesis (typically solid-phase peptide synthesis, or SPPS) produces lyophilized powders that need a compatible diluent
Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihofer C, et al
retrospective analysis of 886 patients found retained gastric contents in 24.2% of semaglutide patients versus 5.1% of controls (adjusted odds ratio 5.15, 95% confidence interval 1.9212.92), yet actual aspiration occurred in only 1 of 404 patients (0.24%) [31]